Default: Clinical Pharmacology and Therapeutics

ISSN: 0009-9236

Journal Home

Journal Guideline

Clinical Pharmacology and Therapeutics Q1 Unclaimed

Wiley-Blackwell United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical Pharmacology and Therapeutics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 188. It has an SJR impact factor of 1,941 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,941.

Clinical Pharmacology and Therapeutics focuses its scope in these topics and keywords: acid, cysteine, drug, clinical, medicines, variability, role, study, trials, allelic, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Clinical Pharmacology and Therapeutics

1,941

SJR Impact factor

188

H Index

404

Total Docs (Last Year)

930

Total Docs (3 years)

13378

Total Refs

4078

Total Cites (3 years)

685

Citable Docs (3 years)

4,03

Cites/Doc (2 years)

33,11

Ref/Doc

Aims and Scope


acid, cysteine, drug, clinical, medicines, variability, role, study, trials, allelic, randomized, evidence, genotype, parkinsons, proteome, rate, approach, childrenlowdose, amino, anagrelide, analgesia, antibodiesassessment, antidote, application,



Best articles by citations

A novel PD model for gatifloxacin (GF) vs. salmonella typhi (ST) in timed kill curves (KC)

View more

Nelfinavir and felodipine: a cytochrome P450 3A4?mediated drug interaction

View more

Effects of age and gender on the pharmacokinetics of lonafarnib (L) following a single oral dose

View more

Enhanced stimulant and metabolic effects of combined ephedrine and caffeine*1

View more

Ethical issues in research with healthy volunteers: risk-benefit assessment

View more

Disposition of Acetaminophen at 4, 6, and 8g/day for 3 Days in Healthy Young Adults

View more

Hair cortisol - a potential biological marker for chronic stress

View more

Comparison of genotypic and phenotypic strategies for individualized therapy with the narrow therapeutic drug warfarin

View more

The impact of timing of chemotherapy relative to darbepoetin alfa (DA) on DA pharmacokinetics (PK) and hematologic effects

View more

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

View more

Gene expression profiles of 4-hydroxy-N-desmethyl-tamoxifen (endoxifen)- and 4-hydroxy-tamoxifen (4OHTAM)-treated human breast cancer cells determined by CDNA microarray analysis

View more

Platelet serotonin (5-HT) reuptake for biomarking SSRI therapeutics in adolescents

View more
SHOW MORE ARTICLES

Ammonia-Lowering Strategies for the Treatment of Hepatic Encephalopathy

View more

Cytochrome P450 eicosanoids regulate fatty acid metabolism via PPARa

View more

Obituary

View more

Implication of cholesterol in cyclosporine pharmacodynamics in minimal change nephrotic syndrome

View more

Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone*

View more

Human liver cytochrome P450 2D6 genotype, full-length messenger ribonucleic acid, and activity assessed with a novel cytochrome P450 2D6 substrate*1

View more

Application of a map Bayesian method for CYP2E1 phenotyping

View more

Pharmacokinetics (PK) of lonafarnib (L), a farnesyl protein transferase inhibitor

View more

N-terminal pro-BNP is a possible early biomarker for the cardiac side-effects of anthracyclines

View more

Severe neutropenia among healthy volunteers given rifabutin in clinical trials

View more

Delayed disposition of cocaine in sweat patches and in skin blister: cocaine may migrate from plasma to sweat patches via interstitial fluid

View more

Ephedra and caffeine produce insulin resistance and hypokalemia in healthy subjects

View more

Comments

No comments ... Be the first to comment!

FAQS